This study also showed a higher risk of blastic transformation of NPM1-mutated CMML (63%) in comparison with NPM1 wild-type CMML (18%) at a median of 5 months after initial diagnosis [122]. Here, NPM1 is linked to chronic myelomonocytic leukemia.